Related Experiment Video
Updated: May 17, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
New treatment in advanced thyroid cancer
Dario Giuffrida1, Angela Prestifilippo, Alessia Scarfia
1Department of Medical Oncology, Mediterranean Institut of Oncology, Via Penninazzo, 7, 95029 Viagrande, Italy.
Journal of Oncology
|November 8, 2012
Summary
New targeted therapies, including tyrosine kinase inhibitors, show promise for advanced thyroid cancer when chemotherapy fails. Further clinical trials are essential to confirm efficacy and optimize treatment strategies for better patient outcomes.
Area of Science:
- Oncology
- Endocrinology
- Pharmacology
Background:
- Thyroid cancer is the most common endocrine malignancy.
- Standard treatments for differentiated thyroid cancer include thyroidectomy, radioactive iodine, and TSH suppression.
- Chemotherapy is largely ineffective for advanced thyroid carcinomas, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review recent literature on novel treatments for advanced nonmedullary and medullary thyroid carcinomas.
- To summarize findings on targeted therapies, including tyrosine kinase and antiangiogenic inhibitors.
- To assess the efficacy and toxicity of emerging treatments in clinical trials.
Main Methods:
- Comprehensive literature search of PubMed, MEDLINE, and EMBASE databases.
- Inclusion of abstracts from relevant scientific meeting proceedings.
- Systematic review and summarization of reported clinical trial data.
Main Results:
- Targeted therapies, such as tyrosine kinase inhibitors and antiangiogenic agents, show potential benefits for thyroid cancer patients.
- Clinical trials report encouraging preliminary results for these novel treatment modalities.
- Toxic effects associated with these new therapies have been documented.
Conclusions:
- Emerging targeted therapies offer a promising avenue for treating advanced thyroid cancer, particularly when conventional chemotherapy is ineffective.
- While current data is encouraging, further extensive clinical trials are required to establish definitive efficacy and refine treatment protocols.
- Continued research is crucial for developing more effective therapies to improve outcomes in thyroid carcinoma management.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...